Tabuteau Herriot Insider Trades

Insider Trading History

Track insider trading activity for Tabuteau Herriot. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $5.57M 24,081 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.41M 24,081 shares
$182.97
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $12.6M 54,623 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.91M 54,623 shares
$163.19
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $9.18M 39,639 shares
Last Trade
Feb 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.02M 32,410 shares
$185.88
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.67M 7,229 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.02M 32,410 shares
$185.60
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.02M 32,410 shares
$185.60
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $8.91M 38,490 shares
Last Trade
Jan 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34M 31,261 shares
$170.69
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.67M 7,229 shares
Last Trade
Jan 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.33M 31,261 shares
$170.38
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $7.5M 32,410 shares
Last Trade
Jan 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.33M 31,261 shares
$170.38
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $8.49M 36,679 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.06M 29,450 shares
$171.88
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.67M 7,229 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.08M 29,450 shares
$172.33
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $14.7M 63,671 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.08M 29,450 shares
$172.33
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.67M 7,229 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.5M 78,703 shares
$171.28
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $21.6M 93,121 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.5M 78,703 shares
$171.28
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $19.9M 85,932 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.5M 78,703 shares
$171.49
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.67M 7,229 shares
Last Trade
Dec 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.56M 10,558 shares
$148.18
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $39.8M 171,824 shares
Last Trade
Dec 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.56M 10,558 shares
$148.18
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $4.12M 17,787 shares
Last Trade
Dec 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.56M 10,558 shares
$148.04
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $6.34M 27,392 shares
Last Trade
Dec 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.98M 20,163 shares
$147.81
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $42.2M 182,382 shares
Last Trade
Dec 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.96M 20,163 shares
$146.94
$231.48
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.67M 7,229 shares
Last Trade
Dec 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.96M 20,163 shares
$146.94
$231.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up